期刊文献+

CART-19在血液恶性肿瘤治疗中的临床应用 被引量:4

下载PDF
导出
摘要 嵌合型抗原受体基因修饰的T细胞(chimeric antigen receptor-modified T cells,CART)免疫疗法是通过基因工程方法改造宿主T细胞,使其能自主靶向结合并杀死肿瘤细胞的治疗方法。该疗法临床研究最多的是CART-19,其是以B细胞表面特异性蛋白CD19为靶抗原的CART细胞,主要用于治疗急性淋巴细胞白血病(acute lymphoblastic leukemia,ALL)、慢性淋巴细胞白血病(chronic lymphocytic leukemia,BLL)和B细胞系肿瘤。文章就CART-19在血液恶性肿瘤中治疗的临床应用进展作一综述。
作者 吴利 罗玉萍
出处 《实用临床医学(江西)》 CAS 2017年第8期105-107,共3页 Practical Clinical Medicine
  • 相关文献

参考文献10

二级参考文献319

  • 1Lipowska-Bhalla G, Gilham DE, Hawkins RE, et al. Targeted immunotherapy of cancer with CAR T cells: Achievements and challenges [ J ]. Cancer Immunol Immunother, 2012, 61 (7) : 953 -962.
  • 2Ramos CA, Dotti G. Chimeric antigen receptor (CAR)-engi- neered lymphocytes for cancer therapy [ J ]. Expert Opin Biol Ther, 2011, 11(7) : 855-873.
  • 3Park TS, Rosenberg SA, Morgan RA. Treating cancer with geneti- cally engineered T cells [ J]. Trends Biotechnol, 2011,29 (11 ) : 550-557.
  • 4Pham CD, Mitchell DA. Chasing cancer with chimeric antigen re- ceptor therapy [J]. Immunotherapy, 2012, 4(4): 365-367.
  • 5Porter DL, Levine BL, Kalos M, et al. Chimeric antigen receptor- modified T cells in chronic lymphoid leukemia [ J ]. N Engl J Med, 2011,365(8) : 725-733.
  • 6Kalos M, Levine BL, Porter DL, et al. T ceils with chimeric anti- gen receptors have potent antitumor effects and can establish mem- ory in patients with advanced leukemia [ J ]. Sci Transl Med, 2311, 3(95) : 95-73.
  • 7Till BG, Jensen MC, Wang J, et al. Adoptive immunotherapy forindolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells [ J ]. Blood, 2008, 112(6): 2261-2271.
  • 8Morgan RA, Dudley ME, Wunderlich JR, et al. Cancer regres- sion in patients after transfer of genetically engineered lymphocytes [J]. Science, 2006, 314(5796) : 126-129.
  • 9Pule MA, Savoldo B, Myers GD, et al. Virus-specific T ceils en- gineered to coexpress tumor specific receptors: Persistence and antitumor activity in individuals with neuroblastoma [ J ]. Nat Med, 2008, 14(11): 1264-1270.
  • 10Wang H, Wei H, Zhang R, et al. Genetically targeted T cells e- radicate established breast cancer in syngeneic mice [J].Clin Cancer Res, 2009, 15(3) : 943-950.

共引文献103

同被引文献26

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部